Aetna has told the outside marketing organizations that sell its Medicare Advantage plans that it will not pay agents or brokers a commission for enrolling new members in 123 of its plans across 33 states for the 2027 plan year. The freeze, distributed in a notice last month, does not cancel a single plan or change a single benefit. What it does is remove the financial reason for a broker to ever bring it up, which matters most for older adults who lean on an agent to sort through Medicare’s options each fall.
A Zero on the Commission Sheet, Not a Cancellation Notice
The CVS Health subsidiary’s freeze covers nearly 780 counties, with roughly one in five of them in Georgia. Aetna will also stop paying agents and brokers for new enrollments in its standalone Medicare Part D prescription drug plans. Nothing about current coverage changes as a result. Anyone already enrolled in one of the 123 plans keeps their provider network, their drug formulary and their existing benefits into 2027; a commission decision affects who gets steered toward a plan next season, not what the plan currently covers.
That distinction matters because of how Medicare enrollment actually works for most people. A large share of beneficiaries choose coverage with help from a broker or a call center, and an agent who earns nothing for placing someone in a given plan has no financial reason to mention it, walk through its details, or spend the time a complex case requires. The plan does not disappear from the market. It disappears from the conversation a shopper is likely to have.
Free retirement updates: Miss an enrollment or claim deadline and it may be gone. Our free Retirement Shield newsletter keeps readers ahead of the ones that matter. Get the free newsletter.
What Federal Pay Caps Reveal About Paying Nothing
The Centers for Medicare and Medicaid Services sets ceilings on what a carrier may pay for a new Medicare Advantage enrollment, and those ceilings are what make a zero meaningful. For the 2027 plan year, CMS’s published compensation schedule generally allows an initial commission of $725 per member per year, with renewals capped at $363, and higher ceilings in a handful of markets, including $816 in Connecticut, Pennsylvania and Washington, D.C., and $902 in California and New Jersey. Standalone Part D commissions rose to a $130 initial cap with $65 for renewals, a roughly 14 percent increase and the largest jump in the schedule. A carrier can pay anywhere up to those limits, or nothing at all. When Aetna wants a plan to grow, it typically pays near the ceiling. Paying zero on 123 plans at once is a signal about which plans the company would rather see shrink quietly.
There is limited public visibility into exactly which plans carry that zero. Insurers had to submit their 2027 compensation schedules to CMS by the end of July, and a newer layer of plan-by-plan reporting that flags where commissions are set at zero exists for 2027, but it is voluntary and is not posted for consumers to check. It is filed through an internal CMS system meant to inform future rulemaking rather than to guide a shopper comparing plans this fall.
A Pattern That Predates This Announcement
Aetna is not new to this tactic. The insurer trimmed commissions on more than two dozen Medicare Advantage plans across 10 markets in 2024, and Cigna and Elevance have each pulled back broker payments during subsequent enrollment periods, in some cases mid-season. Regulatory changes are compounding the shift: the contract year 2027 final rule also rolled back marketing safeguards adopted in 2023, including the 48-hour waiting period that had been required between a signed scope of appointment and a marketing appointment, with most of those changes taking effect October 1. A federal court separately vacated portions of CMS’s 2025 compensation methodology, and the agency reverted to its earlier approach when it calculated the 2027 limits that now apply.
What a Medicare Shopper Can Still Check
Medicare’s annual open enrollment period runs from October 15 through December 7, and the practical risk falls hardest on people with complicated health needs, including anyone managing multiple chronic conditions, taking specialty medications or seeing a particular specialist, since the plan that fits their situation could be one nobody is being paid to mention. Free help exists regardless of whether a plan is commissioned: State Health Insurance Assistance Programs offer counseling in every state at no cost, and their counselors do not work on commission. Medicare’s own plan finder tool allows a side-by-side comparison of every plan available in a county, including ones a broker’s pitch might skip.
Two checks apply no matter who does the shopping: confirming that specific doctors are in-network for the coming plan year rather than the current one, and running an actual prescription list through a plan’s formulary, since both networks and drug lists reset annually. A frozen commission says nothing about a plan’s quality. It says a great deal about how likely a beneficiary is to hear about that plan before December 7 arrives.
What the plan letter does not do
An Annual Notice of Change lists what changed, but never compares the plan against the alternatives on cost, drugs and doctors.
The 2027 Medicare Open Enrollment Decision Kit includes a 42-page decision kit, a cost calculator spreadsheet that compares plans on cost, drugs and doctors and a prescription-by-plan comparison.
Run the comparison in The 2027 Medicare Open Enrollment Decision Kit.
This article was assisted by AI tools and reviewed for accuracy before publication.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
